Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice Concerning Disposal of Treasury Shares as Restricted Stock for Employee Shareholding Association
Consolidated Financial Results for the Nine Months Ended December 31, 2025 [Japanese GAAP]
Notice Concerning Revisions to Dividend Forecast (Implementation of Commemorative Dividend for the 80th Anniversary of the
Supplementary Explanatory Materials on Financial Results for the Nine Months Ended December 31, 2025
Marketing Authorization Approval in Japan for Yselty Tablets 100mg, an Oral GnRH Antagonist, Indicated for Uterine Fibroids
Notice of Change to Scheduled Date to Commence Dividend Payments
Financial Briefing for the Second Quarter (Interim) of the Fiscal Year Ended March 31, 2026 (Fiscal 2025)
Notice Concerning Revisions to Financial Results Forecast
Consolidated Financial Results for the Six Months Ended September 30, 2025 [Japanese GAAP]
Supplementary Explanatory Materials on Financial Results for the Six Months Ended September 30, 2025
Linzagolix Approved for Marketing in Taiwan
Licensing Agreement for "Linzagolix" with Searchlight Pharma in Canada
Notice Regarding Sale of Investment Securities (Result)
Licensing Agreement with Viridian Therapeutics for "Veligrotug" and "VRDN-003" in Treatment of Thyroid Eye Disease
Notice Concerning Revisions to Financial Results Forecast and Recording of Extraordinary Income
Supplementary Explanatory Materials on Financial Results for the Three Months Ended June 30, 2025
Consolidated Financial Results for the Three Months Ended June 30, 2025 [Japanese GAAP]
Notice Regarding Completion of Disposal of Treasury Stocks as Restricted Stock for Members of the Board and Corporate Officers
New Launch of TAVALISSE for Chronic Idiopathic Thrombocytopenic Purpura Treatment in South Korea
Notice Concerning Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate Officers